Passer au contenu Aller au pied de page
Siponimod: Benefits, Reviews, Info, Side Effects!
Détails de la prescription
Mayzent, BAF312
Siponimod
Drug
Médicaments
Sur ordonnance uniquement
reduction in multiple sclerosis relapses, slowing of disability progression, reduction in brain volume loss, oral administration, selective targeting of S1P receptors, potential improvement in cognitive function
Back Pain, Cough, Diarrhea, Dizziness, Headache, High Blood Pressure, Infections, Liver Function Test Abnormalities, Nausea, Slow Heart Rate, Swelling Of The Extremities
Siponimod, marketed under the brand name Mayzent, is a medication used to treat multiple sclerosis. The typical dosage for Siponimod is determined based on a titration schedule and the patient’s CYP2C9 genotype, which affects how the drug is metabolized. For most patients, the treatment begins with a titration phase over the first 5 days: – Day 1: 0.25 mg – Day 2: 0.25 mg – Day 3: 0.5 mg – Day 4: 0.75 mg – Day 5: 1.25 mg After the titration phase, the maintenance dose is usually 2 mg once daily, starting on Day 6. However, for patients with certain CYP2C9 genotypes (specifically *1/*3 or *2/*3), the maintenance dose may be adjusted to 1 mg once daily. It is important for patients to follow their healthcare provider’s instructions and undergo genetic testing to determine the appropriate dosage. Always consult a healthcare professional for personalized medical advice.
Multiple sclerosis
Siponimod has a generally favorable safety profile.
Aucune interaction signalée
$1,000 – $1,500
$8,000 for a 30day supply.

Un résumé de

Siponimod

Siponimod is a medication that belongs to a class of drugs known as sphingosine-1-phosphate receptor modulators. It is primarily used in the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of relapses and delay the progression of disability.

This medication works by binding to specific receptors on immune cells, preventing them from entering the central nervous system where they can cause damage to the myelin sheath surrounding nerve fibers. By reducing the number of immune cells in the brain and spinal cord, siponimod helps to decrease inflammation and protect against further nerve damage.

It is important to follow your healthcare provider’s instructions carefully when taking siponimod. This medication is typically taken once daily, with or without food. It is important to not miss any doses and to take the medication at the same time each day to maintain consistent levels in your body.

As with any medication, siponimod may cause side effects in some individuals. Common side effects may include headache, high blood pressure, liver enzyme elevations, and respiratory infections. It is important to report any side effects to your healthcare provider promptly.

Before starting siponimod, it is important to discuss your medical history and any other medications or supplements you are taking with your healthcare provider. They can help determine if siponimod is the right treatment option for you and monitor your progress while taking the medication.

Overall, siponimod can be an effective treatment option for individuals with relapsing forms of MS. By working to reduce inflammation and protect against nerve damage, siponimod can help improve symptoms and slow the progression of disability in those living with this chronic condition.

Avis de non-responsabilité juridique de RxDb

Les informations fournies sur RxDB.net sont fournies à titre informatif uniquement et ne sont pas destinées à remplacer un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours un professionnel de la santé qualifié, tel qu'un médecin ou un pharmacien, pour toute question ou préoccupation concernant votre santé, vos médicaments ou votre état de santé. Vous vous fiez entièrement aux informations fournies sur ce site Web à vos propres risques. RxDB.net ne fournit pas de services médicaux ou pharmaceutiques et n'est pas responsable des décisions prises sur la base des informations contenues dans le présent document.

DERNIÈRE MISE À JOUR DE LA PAGE

0
J'aimerais connaître votre avis, n'hésitez pas à commenter.x
fr_CAFR